JBM (Healthcare) Limited (2161.HK)

0,980 -0,010 (-1,01%) Börsenschluss: 03:23PM HKT

JBM (Healthcare) Limited

Unit 808-811
C-Bons International Centre, 8th Floor 108 Wai Yip Street
Kwun Tong
Hong Kong
852 2267 2182
https://www.jbmhealthcare.com.hk

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Yat Wai Wong	CEO & Executive Director	2,81M	N/A	1963
Mr. Kau Lap Lam	VP of Finance	N/A	N/A	1986
Ms. Hoi Ki Leung	Operation Manager	N/A	N/A	1982
Ms. Chui Yee Lo	Senior Marketing Manager	N/A	N/A	1969
Dr. Heung Kwan Cheng	Executive Director	N/A	N/A	1962
Mr. Chun Kau Yu ACS, FCPA	Company Secretary	N/A	N/A	1973

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in HKD.

Beschreibung

JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded, healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment develops, manufactures, and distributes registered Chinese medicines composed of Chinese herbal medicines. The Health and Wellness Products segment distributes and sells supplements, medical consumables, and other nonpharmaceutical products for the general health and wellness of consumers. The company offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and medicated and non-medicated solutions, as well as diagnostic devices. It is also involved in the trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong. JBM (Healthcare) Limited is a subsidiary of JBM Group (BVI) Limited.

Corporate Governance

JBM (Healthcare) Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.